Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Avanos Medical Inc (AVNS)

Avanos Medical Inc (AVNS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,432,118
  • Shares Outstanding, K 48,187
  • Annual Sales, $ 714,800 K
  • Annual Income, $ -27,200 K
  • 60-Month Beta 0.85
  • Price/Sales 2.05
  • Price/Cash Flow 18.08
  • Price/Book 1.16
Trade AVNS with:

Options Overview Details

View History
  • Implied Volatility 51.71%
  • Historical Volatility 36.48%
  • IV Percentile 88%
  • IV Rank 68.01%
  • IV High 62.54% on 04/15/21
  • IV Low 28.70% on 06/16/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 3
  • Volume Avg (30-Day) 22
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 4
  • Open Int (30-Day) 266

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/21
See More
  • Average Estimate 0.40
  • Number of Estimates 3
  • High Estimate 0.41
  • Low Estimate 0.39
  • Prior Year 0.28
  • Growth Rate Est. (year over year) +42.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
29.13 +2.03%
on 12/02/21
36.11 -17.70%
on 11/04/21
-6.30 (-17.49%)
since 11/03/21
3-Month
29.13 +2.03%
on 12/02/21
36.44 -18.44%
on 11/03/21
-3.17 (-9.64%)
since 09/03/21
52-Week
29.13 +2.03%
on 12/02/21
53.61 -44.56%
on 02/18/21
-13.83 (-31.76%)
since 12/03/20

Most Recent Stories

More News
Avanos Medical (AVNS) Down 17.6% Since Last Earnings Report: Can It Rebound?

Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

AVNS : 29.72 (-2.43%)
Avanos Medical (AVNS) Q3 Earnings Lag Estimates, Revenues Top

Avanos Medical's (AVNS) third-quarter 2021 results gains from strength in the Pain Management segment.

TMO : 636.11 (+1.36%)
WST : 434.13 (-0.75%)
CHE : 469.99 (-1.19%)
AVNS : 29.72 (-2.43%)
Avanos Medical (AVNS) Q3 Earnings Lag Estimates

Avanos Medical (AVNS) delivered earnings and revenue surprises of -7.41% and 0.11%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

AVNS : 29.72 (-2.43%)
Avanos Medical, Inc. To Webcast Conference Call Discussing Third Quarter 2021 Financial Results

/PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the third quarter...

AVNS : 29.72 (-2.43%)
MiMedx Announces Concurrent $150 Million Private Equity and Debt Financings

Equity Financing Led by EW Healthcare Partners and Debt Financing Provided by Hayfin Capital Management

MDXG : 6.81 (-2.44%)
BIIB : 223.92 (-2.01%)
AVNS : 29.72 (-2.43%)
ABMD : 300.63 (-3.78%)
INVESTOR ALERT: Fields Kupka & Shukurov LLP Is Investigating Avanos Medical, Inc. for Potential Breach of Fiduciary Duty Claims

NEW YORK, March 18, 2020 (GLOBE NEWSWIRE) -- Fields Kupka & Shukurov LLP is investigating potential breach of fiduciary duty claims involving the board of directors of Avanos Medical, Inc. (NYSE: AVNS...

AVNS : 29.72 (-2.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Avanos Medical Inc. operates as a medical technology company. It offers infection prevention, surgical, respiratory, digestive health and pain management solutions. Avanos Medical Inc., formerly known as Halyard Health Inc., is headquartered in Alpharetta, Georgia.

See More

Key Turning Points

3rd Resistance Point 31.79
2nd Resistance Point 31.27
1st Resistance Point 30.50
Last Price 29.72
1st Support Level 29.21
2nd Support Level 28.69
3rd Support Level 27.92

See More

52-Week High 53.61
Fibonacci 61.8% 44.26
Fibonacci 50% 41.37
Fibonacci 38.2% 38.48
Last Price 29.72
52-Week Low 29.13

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar